Different Units By MoH Code
Revision Date : 11/01/2013
NovoSeven RT 50KIU MoH 5540 :
Form |
Powder and solvent for solution for injection |
Packaging |
Pre-filled Syringes + Vials (Type I glass) |
Package Size |
1+1 |
Strength |
1mg (50KIU) |
Public Price |
70202353,84 L.L. |
Stratum |
E1 |
NSSF |
✔ |
Quarantine |
✔ |
Reg. Number |
218019/09 |
Submission date |
01/01/2009 |
Registration Year |
2009 |
●
Country:
|
Italy
|
●
Package Size:
|
1+1x1.1ml
|
●
Public Price:
|
1079.12 EUR
|
( 19,834,279.56 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1079,12 EUR
|
( 19,832,073.95 LBP )
|
●
Exfactory Price:
|
653.85 EUR
|
●
Pricing Date:
|
17/12/2019
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Germany
|
●
Package Size:
|
1
|
●
Public Price:
|
927.81 EUR
|
( 17,053,194.19 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
927,81 EUR
|
( 17,038,306.35 LBP )
|
●
Pricing Date:
|
24/10/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Qatar
|
●
Package Size:
|
1 powder vial + 1 Solvent pre-filled syringe + vial adapter
|
●
Public Price:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
●
Pharmacy Price:
|
3255.49386266 QAR
|
( 13512122.606602 LBP )
|
●
Pricing Date:
|
28/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Oman
|
●
Package Size:
|
1+1
|
●
Public Price:
|
417.29 OMR
|
( 16,399,705.65 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
417,29 OMR
|
( 16,388,308.50 LBP )
|
●
Pricing Date:
|
19/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Kuweit
|
●
Package Size:
|
1+1
|
●
Public Price:
|
319.2 KWD
|
( 15,822,769.54 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
319,2 KWD
|
( 15,812,855.52 LBP )
|
●
Pharmacy Price:
|
269.67 KWD
|
( 13367563.4736 LBP )
|
●
Pricing Date:
|
07/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Switzerland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
907.55 CHF
|
( 15,483,029.89 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
907,55 CHF
|
( 15,473,646.75 LBP )
|
●
Exfactory Price:
|
845.41 CHF
|
●
Pricing Date:
|
04/04/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
UAE
|
●
Package Size:
|
1 Vial (Powder) + 1 Solvent Vial (1.1ml)
|
●
Public Price:
|
3703 AED
|
( 15,222,884.88 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
●
Pharmacy Price:
|
3154.78 AED
|
( 12969174.3888 LBP )
|
●
Pricing Date:
|
21/08/2019
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Abu Dhabi
|
●
Package Size:
|
1+1x1.1ml
|
●
Public Price:
|
3703 AED
|
( 15,222,884.88 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
●
Pharmacy Price:
|
3154.78 AED
|
( 12969174.3888 LBP )
|
●
Pricing Date:
|
27/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Finland
|
●
Package Size:
|
1+1x1ml
|
●
Public Price:
|
809.89 EUR
|
( 14,885,818.69 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
809,89 EUR
|
( 14,869,460.45 LBP )
|
●
Reference:
|
Kela
|
●
Pricing Date:
|
22/04/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Bahrain
|
●
Package Size:
|
1+1
|
●
Public Price:
|
352.25 BHD
|
( 14,132,541.23 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
352,25 BHD
|
( 14,122,511.04 LBP )
|
●
Reference:
|
nhra
|
●
Pricing Date:
|
09/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Denmark
|
●
Package Size:
|
1+1
|
●
Public Price:
|
5318.1 DKK
|
( 13,087,684.56 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
5318,1 DKK
|
( 13,087,438.46 LBP )
|
●
Pharmacy Price:
|
3948.91 DKK
|
( 9718149.0427 LBP )
|
●
Reference:
|
Danish Medicine Agency
|
●
Pricing Date:
|
19/05/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Iceland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
●
Pharmacy Price:
|
84672 ISK
|
( 9386737.92 LBP )
|
●
Reference:
|
Icelandic Medicines Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Czech Republic
|
●
Package Size:
|
1+1x1ml
|
●
Public Price:
|
17583.04 CZK
|
( 12,145,660.71 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
17583,04 CZK
|
( 12,145,633.08 LBP )
|
●
Reference:
|
SUKL
|
●
Pricing Date:
|
28/02/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Greece
|
●
Package Size:
|
1+1
|
●
Public Price:
|
642.66 EUR
|
( 11,812,122.93 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
642,66 EUR
|
( 11,799,992.10 LBP )
|
●
Reference:
|
National Organization for Medicines
|
●
Pricing Date:
|
25/03/2019
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
Spain
|
●
Package Size:
|
1 vial + 1xdisolvente
|
●
Public Price:
|
639 EUR
|
( 11,744,851.95 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
639 EUR
|
( 11,744,851.95 LBP )
|
●
Reference:
|
Agencia Española de Medicamentos y Productos Sanitarios
|
●
Pricing Date:
|
06/05/2021
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
France
|
●
Package Size:
|
1+1
|
●
Public Price:
|
608 EUR
|
( 11,175,070.40 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
608 EUR
|
( 11,175,070.40 LBP )
|
●
Reference:
|
ansm
|
●
Pricing Date:
|
15/05/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
KSA
|
●
Package Size:
|
1mg
|
●
Public Price:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
●
Reference:
|
sfda
|
●
Pricing Date:
|
16/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
UK
|
●
Package Size:
|
1+1
|
●
Public Price:
|
525.2 GBP
|
( 10,583,184.40 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
525,2 GBP
|
( 10,579,154.25 LBP )
|
●
Reference:
|
DMD
|
●
Pricing Date:
|
08/03/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Norway
|
●
Package Size:
|
1
|
●
Public Price:
|
6048.4 NOK
|
( 10,465,365.07 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
6048,4 NOK
|
( 10,464,672.96 LBP )
|
●
Pharmacy Price:
|
4715.41 NOK
|
( 8158932.4607 LBP )
|
●
Reference:
|
Norwegian Medicine Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Sweden
|
●
Package Size:
|
1+1
|
●
Public Price:
|
5733.56 SEK
|
( 10,321,038.69 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
5733,56 SEK
|
( 10,320,030.63 LBP )
|
●
Pharmacy Price:
|
5575.79 SEK
|
( 10037035.3369 LBP )
|
●
Pricing Date:
|
23/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Belgium
|
●
Package Size:
|
1+1x1.1ml
|
●
Public Price:
|
532 EUR
|
( 9,778,186.60 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
532 EUR
|
( 9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
●
Pricing Date:
|
02/12/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Lebanon
|
●
Form:
|
Powder and solvent for solution for injection
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
●
Pricing Date:
|
10/01/2024
|
●
Country:
|
The Netherlands
|
●
Package Size:
|
1
|
●
Reference:
|
Zorginstituut Nederland
|
●
Pricing Date:
|
15/06/2019
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
New Zealand
|
●
Package Size:
|
1 inj
|
●
Exfactory Price:
|
1178.3 NZD
|
●
Reference:
|
New Zealand Pharmaceutical Management Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Portugal
|
●
Package Size:
|
1+1
|
●
Reference:
|
Autoridade Nacional do Medicamento e Produtos de Saúde
|
●
Pricing Date:
|
22/04/2019
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
1079,12 EUR
|
( 19,832,073.95 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
1079,12 EUR
|
( 19,832,073.95 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
1079,12 EUR
|
( 19,832,073.95 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
1079,12 EUR
|
( 19,832,073.95 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1079,12 EUR
|
( 19,832,073.95 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
927,81 EUR
|
( 17,038,306.35 LBP )
|
● Cost/Day:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
●
Cost/Month:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
927,81 EUR
|
( 17,038,306.35 LBP )
|
● Cost/Day:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
●
Cost/Month:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
927,81 EUR
|
( 17,038,306.35 LBP )
|
● Cost/Day:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
●
Cost/Month:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
927,81 EUR
|
( 17,038,306.35 LBP )
|
● Cost/Day:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
●
Cost/Month:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
927,81 EUR
|
( 17,038,306.35 LBP )
|
● Cost/Day:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
●
Cost/Month:
|
5566,86 EUR
|
( 102,303,358.30 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
● Cost/Day:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
●
Cost/Month:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
● Cost/Day:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
●
Cost/Month:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
● Cost/Day:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
●
Cost/Month:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
● Cost/Day:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
●
Cost/Month:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
3963 QAR
|
( 16,448,669.28 LBP )
|
● Cost/Day:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
●
Cost/Month:
|
23778 QAR
|
( 98,692,015.68 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
417,29 OMR
|
( 16,388,308.50 LBP )
|
● Cost/Day:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
417,29 OMR
|
( 16,388,308.50 LBP )
|
● Cost/Day:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
417,29 OMR
|
( 16,388,308.50 LBP )
|
● Cost/Day:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
417,29 OMR
|
( 16,388,308.50 LBP )
|
● Cost/Day:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
417,29 OMR
|
( 16,388,308.50 LBP )
|
● Cost/Day:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,74 OMR
|
( 98,369,151.50 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
319,2 KWD
|
( 15,812,855.52 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
319,2 KWD
|
( 15,812,855.52 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
319,2 KWD
|
( 15,812,855.52 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
319,2 KWD
|
( 15,812,855.52 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
319,2 KWD
|
( 15,812,855.52 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
907,55 CHF
|
( 15,473,646.75 LBP )
|
● Cost/Day:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
●
Cost/Month:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
907,55 CHF
|
( 15,473,646.75 LBP )
|
● Cost/Day:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
●
Cost/Month:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
907,55 CHF
|
( 15,473,646.75 LBP )
|
● Cost/Day:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
●
Cost/Month:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
907,55 CHF
|
( 15,473,646.75 LBP )
|
● Cost/Day:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
●
Cost/Month:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
907,55 CHF
|
( 15,473,646.75 LBP )
|
● Cost/Day:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
●
Cost/Month:
|
5445,3 CHF
|
( 92,893,061.25 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
3703 AED
|
( 15,222,884.88 LBP )
|
● Cost/Day:
|
22218 AED
|
( 91,337,309.28 LBP )
|
●
Cost/Month:
|
22218 AED
|
( 91,337,309.28 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
809,89 EUR
|
( 14,869,460.45 LBP )
|
● Cost/Day:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
●
Cost/Month:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
809,89 EUR
|
( 14,869,460.45 LBP )
|
● Cost/Day:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
●
Cost/Month:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
809,89 EUR
|
( 14,869,460.45 LBP )
|
● Cost/Day:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
●
Cost/Month:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
809,89 EUR
|
( 14,869,460.45 LBP )
|
● Cost/Day:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
●
Cost/Month:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
809,89 EUR
|
( 14,869,460.45 LBP )
|
● Cost/Day:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
●
Cost/Month:
|
4859,34 EUR
|
( 89,308,662.95 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
352,25 BHD
|
( 14,122,511.04 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
352,25 BHD
|
( 14,122,511.04 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
352,25 BHD
|
( 14,122,511.04 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
352,25 BHD
|
( 14,122,511.04 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
352,25 BHD
|
( 14,122,511.04 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
5318,1 DKK
|
( 13,087,438.46 LBP )
|
● Cost/Day:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
●
Cost/Month:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
5318,1 DKK
|
( 13,087,438.46 LBP )
|
● Cost/Day:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
●
Cost/Month:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
5318,1 DKK
|
( 13,087,438.46 LBP )
|
● Cost/Day:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
●
Cost/Month:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
5318,1 DKK
|
( 13,087,438.46 LBP )
|
● Cost/Day:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
●
Cost/Month:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
5318,1 DKK
|
( 13,087,438.46 LBP )
|
● Cost/Day:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
●
Cost/Month:
|
31908,6 DKK
|
( 78,524,630.76 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
● Cost/Day:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
●
Cost/Month:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
● Cost/Day:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
●
Cost/Month:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
● Cost/Day:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
●
Cost/Month:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
● Cost/Day:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
●
Cost/Month:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
110287 ISK
|
( 12,226,416.82 LBP )
|
● Cost/Day:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
●
Cost/Month:
|
661722 ISK
|
( 73,358,500.92 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
17583,04 CZK
|
( 12,145,633.08 LBP )
|
● Cost/Day:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
●
Cost/Month:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
17583,04 CZK
|
( 12,145,633.08 LBP )
|
● Cost/Day:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
●
Cost/Month:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
17583,04 CZK
|
( 12,145,633.08 LBP )
|
● Cost/Day:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
●
Cost/Month:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
17583,04 CZK
|
( 12,145,633.08 LBP )
|
● Cost/Day:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
●
Cost/Month:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
17583,04 CZK
|
( 12,145,633.08 LBP )
|
● Cost/Day:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
●
Cost/Month:
|
105498,24 CZK
|
( 72,873,798.48 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
642,66 EUR
|
( 11,799,992.10 LBP )
|
● Cost/Day:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
●
Cost/Month:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
642,66 EUR
|
( 11,799,992.10 LBP )
|
● Cost/Day:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
●
Cost/Month:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
642,66 EUR
|
( 11,799,992.10 LBP )
|
● Cost/Day:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
●
Cost/Month:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
642,66 EUR
|
( 11,799,992.10 LBP )
|
● Cost/Day:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
●
Cost/Month:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
642,66 EUR
|
( 11,799,992.10 LBP )
|
● Cost/Day:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
●
Cost/Month:
|
3855,96 EUR
|
( 70,855,092.75 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
639 EUR
|
( 11,744,851.95 LBP )
|
● Cost/Day:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
●
Cost/Month:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
639 EUR
|
( 11,744,851.95 LBP )
|
● Cost/Day:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
●
Cost/Month:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
639 EUR
|
( 11,744,851.95 LBP )
|
● Cost/Day:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
●
Cost/Month:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
639 EUR
|
( 11,744,851.95 LBP )
|
● Cost/Day:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
●
Cost/Month:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
639 EUR
|
( 11,744,851.95 LBP )
|
● Cost/Day:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
●
Cost/Month:
|
3834 EUR
|
( 70,469,111.70 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
608 EUR
|
( 11,175,070.40 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
608 EUR
|
( 11,175,070.40 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
608 EUR
|
( 11,175,070.40 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
608 EUR
|
( 11,175,070.40 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
608 EUR
|
( 11,175,070.40 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
● Cost/Day:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
●
Cost/Month:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
● Cost/Day:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
●
Cost/Month:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
● Cost/Day:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
●
Cost/Month:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
● Cost/Day:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
●
Cost/Month:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
2640 SAR
|
( 10,640,203.20 LBP )
|
● Cost/Day:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
●
Cost/Month:
|
15840 SAR
|
( 63,841,219.20 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
525,2 GBP
|
( 10,579,154.25 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
525,2 GBP
|
( 10,579,154.25 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
525,2 GBP
|
( 10,579,154.25 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
525,2 GBP
|
( 10,579,154.25 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
525,2 GBP
|
( 10,579,154.25 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
6048,4 NOK
|
( 10,464,672.96 LBP )
|
● Cost/Day:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
●
Cost/Month:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
6048,4 NOK
|
( 10,464,672.96 LBP )
|
● Cost/Day:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
●
Cost/Month:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
6048,4 NOK
|
( 10,464,672.96 LBP )
|
● Cost/Day:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
●
Cost/Month:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
6048,4 NOK
|
( 10,464,672.96 LBP )
|
● Cost/Day:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
●
Cost/Month:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
6048,4 NOK
|
( 10,464,672.96 LBP )
|
● Cost/Day:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
●
Cost/Month:
|
36290,4 NOK
|
( 62,791,498.30 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
5733,56 SEK
|
( 10,320,030.63 LBP )
|
● Cost/Day:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
●
Cost/Month:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
5733,56 SEK
|
( 10,320,030.63 LBP )
|
● Cost/Day:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
●
Cost/Month:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
5733,56 SEK
|
( 10,320,030.63 LBP )
|
● Cost/Day:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
●
Cost/Month:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
5733,56 SEK
|
( 10,320,030.63 LBP )
|
● Cost/Day:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
●
Cost/Month:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
5733,56 SEK
|
( 10,320,030.63 LBP )
|
● Cost/Day:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
●
Cost/Month:
|
34401,36 SEK
|
( 61,925,584.11 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
532 EUR
|
( 9,778,186.60 LBP )
|
● Cost/Day:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
●
Cost/Month:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
532 EUR
|
( 9,778,186.60 LBP )
|
● Cost/Day:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
●
Cost/Month:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
532 EUR
|
( 9,778,186.60 LBP )
|
● Cost/Day:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
●
Cost/Month:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
532 EUR
|
( 9,778,186.60 LBP )
|
● Cost/Day:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
●
Cost/Month:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
532 EUR
|
( 9,778,186.60 LBP )
|
● Cost/Day:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
●
Cost/Month:
|
3192 EUR
|
( 58,669,119.60 LBP )
|
Acquired haemophilia :
(Adults)
●
Cost/Unit:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
● Cost/Day:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
●
Cost/Month:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
Congenital FVII deficiency :
(Adults)
●
Cost/Unit:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
● Cost/Day:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
●
Cost/Month:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
(Adults)
●
Cost/Unit:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
● Cost/Day:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
●
Cost/Month:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
(Adults)
●
Cost/Unit:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
● Cost/Day:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
●
Cost/Month:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1145093 LBP
|
( 1,145,093.00 LBP )
|
● Cost/Day:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
●
Cost/Month:
|
6870558 LBP
|
( 6,870,558.00 LBP )
|
Prices are provided in Dollar ($)
You have to register to view this info
You have to register to view this info